Mackay Shields LLC Durect Corp Transaction History

Mackay Shields LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$1.65 - $2.43 $99,660 - $146,772	-60,400 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$1.6 - $2.35 $328,640 - $482,690	-205,400 Reduced 77.28%	60,400 $103,000
Q2 2020 Jul 31, 2020	BUY	$1.33 - $2.76 $353,514 - $733,608	265,800 New	265,800 $617,000
Q2 2019 Aug 13, 2019	SELL	$0.51 - $0.86 $80,029 - $134,952	-156,921 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$0.51 - $0.82 $10,404 - $16,728	-20,400 Reduced 11.5%	156,921 $98,000
Q4 2018 Feb 14, 2019	SELL	$0.48 - $1.1 $13,765 - $31,546	-28,679 Reduced 13.92%	177,321 $86,000
Q3 2018 Nov 14, 2018	SELL	$1.06 - $1.69 $45,686 - $72,839	-43,100 Reduced 17.3%	206,000 $227,000
Q2 2018 Aug 06, 2018	BUY	$1.56 - $2.51 $121,212 - $195,026	77,700 Added 45.33%	249,100 $389,000
Q1 2018 May 03, 2018	BUY	$0.91 - $2.24 $155,974 - $383,936	171,400 New	171,400 $367,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $216M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.